Davis v. U.S.

• Decision Date: 28 May 1981
• Docket Number: No. 77-1942,77-1942
• Citation: 642 F.2d 328
• Parties: Glynn Richard DAVIS, Plaintiff-Appellant, v. UNITED STATES of America, Defendant-Appellee.
• Court: U.S. Court of Appeals — Ninth Circuit

Page 328

642 F.2d 328

Glynn Richard DAVIS, Plaintiff-Appellant, v. UNITED STATES of America, Defendant-Appellee.

No. 77-1942.

United States Court of Appeals Ninth Circuit.

Argued and Submitted Dec. 12, 1979.

Decided April 20, 1981.

Rehearing and Rehearing In Banc Denied May 28, 1981.

Blaine Evans, Boise, Idaho, and Avrm G. Alder, Freedman, Borowsky & Lorry, Philadelphia, Pa., for plaintiff-appellant.

William Kanter, Civil Division, Washington, D.C., for defendant-appellee.

Appeal from the United States District Court for the District of Idaho.

Before MERRILL, TANG and SCHROEDER, Circuit Judges.

MERRILL, Circuit Judge:

Background

The Sabin Type III oral polio vaccine was administered to appellant Davis as part of a nationwide campaign initiated by the government of the United States to eradicate paralytic poliomyelitis (polio) in this country. Mass immunization centers were established in cooperation with state and local medical authorities, and the campaign was widely publicized. ¹ The Division of Biologic Standards (DBS) of the National Institutes of Health, a part of the United States Department of Health, Education and Welfare, was charged with testing and licensing manufacture of the vaccine, pursuant to 42 C.F.R. § 73.110 et seq.

The vaccine was administered to appellant Davis at one of these centers in March, 1963. Within thirty days, appellant was paralyzed from the waist down and exhibited other symptoms of polio. Davis brought suit against the manufacturer of the drug, Wyeth Laboratories, Inc., in 1964.

In the course of that litigation, in October, 1965, defendant Wyeth Laboratories, Inc., noticed the deposition of Dr. Ruth Kirschstein, the chief of the pathology section of the laboratory of Viral Immunology, DBS, accompanied by a subpoena duces tecum ordering her to bring to the deposition, inter alia, all records of DBS relating to lot No. 03503 of the Sabin Type III oral polio vaccine. The vaccine ingested by Davis was from this lot. Appellant's attorney was present at this deposition. Dr. Kirschstein brought with her records documenting the results of a single neurovirulence test; ² the results fell within acceptable limits. ³

Appellant alleges that not until 1973 did he learn from an attorney representing a plaintiff in another suit ⁴ that DBS had conducted another neurovirulence test on lot No. 03503, and that the results of that test did not fall within the acceptable range. ⁵ In April, 1973, appellant filed a notice of claim under the Federal Tort Claims Act (FTCA) 28 U.S.C. § 1346 et seq., and in April, 1974, brought the instant action in the court below.

The district court granted summary judgment for the United States, holding that Davis' suit was barred by the two-year statute of limitations which applies to all actions brought under the FTCA. 28 U.S.C. § 2401(b).

Davis appeals, contending that either: (1) the cause of action did not accrue until he learned, in 1973, of the facts indicating the government's responsibility for his paralysis; or (2) the statute was tolled by the government's fraudulent concealment of the results of the second test.

We affirm the district court's grant of summary judgment.

Accrual of the Action

A two-year statute of limitations applies to all suits brought under the FTCA. 28 U.S.C. § 2401(b). ⁶ Appellant contends, however, that under the so-called "discovery rule" applied in medical malpractice cases, the cause of action did not accrue and the statute did not begin to run until he learned, in 1973, of the results of the second neurovirulence test. United States v. Kubrick, 444 U.S. 111, 100 S.Ct. 352, 62 L.Ed.2d 259 (1979), is cited in support of the proposition that the action accrues when the plaintiff learns, or, in the exercise of reasonable diligence should have learned, of his injury and of the actions that caused it. 444 U.S. at 123-24, 100 S.Ct. at 360-61. While the present case is not technically one involving medical malpractice, it is in many ways similar to such an action, ⁷ and we will assume, arguendo, that it should be assimilated to the category of medical malpractice for statute of limitations purposes. Nonetheless, we conclude that appellant's claim is barred by the statute.

The general rule in tort law is that the claim accrues at the time of the plaintiff's injury. In the area of medical malpractice this has been felt to be unduly harsh in those cases where the fact of injury remains undisclosed. The rule accordingly has widely been modified to provide that a claim does not accrue until the injury has manifested itself. Urie v. Thompson, 337 U.S. 163, 69 S.Ct. 1018, 93 L.Ed.2d 1282 (1949). The Restatement (Second) of Torts § 899, Comment e, quoted in United States v. Kubrick, supra, 444 U.S. at 120 n.7, 100 S.Ct. at 358 n.7, reflects this change:

"In a wave of recent decisions (it has been held) that the statute must be construed as not intended to start to run until the plaintiff has in fact discovered the fact that he has suffered injury or by the exercise of reasonable diligence should have discovered it."

In Kubrick, the Court assumed that the discovery rule should be further modified to provide that accrual does not occur, and thus that the statute of limitations does not commence to run, until the plaintiff has discovered, or, in the exercise of reasonable diligence should have discovered, both his injury and its cause. ⁸ The Court noted that "the United States was prepared to concede as much for present purposes," id. at 120-21, 100 S.Ct. at 358-59.) The question presented was whether the rule should be still further extended to defer accrual until the plaintiff had, or, in the exercise of reasonable diligence should have had, knowledge of the defendant's negligence. The Court approached this question as one involving the construction of § 2401(b). It stated:

"(We) are not free to construe it so as to defeat its obvious purpose, which is to encourage the prompt presentation of claims. (Citations omitted). We should regard the plea of limitations as a 'meritorious defense, in itself serving a public interest.' (Citations omitted)."

Id. at 117, 100 S.Ct. at 357.

The Court then made it plain that it was not prepared to go further than the government concession. It refused to defer accrual until fault as well as injury and cause had been discovered; it would not hold that "the statute is not to run until the plaintiff is led to suspect negligence." Id. at 124, 100 S.Ct. at 360.

With knowledge of the fact of injury and its cause the malpractice plaintiff is on the same footing as any negligence plaintiff. The burden is then on plaintiff to ascertain the existence and source of fault within the statutory period. It follows that diligence or lack of diligence in these efforts is irrelevant. In the absence of fraudulent concealment it is plaintiff's burden, within the statutory period, to determine whether and whom to sue. Kubrick makes this plain. Once a plaintiff knows that harm has been done to him, he must, the Court states, "determine within the period of limitations whether to sue or not, which is precisely the judgment that other tort claimants must make. If he fails to bring suit because he is incompetently or mistakenly told that he does not have a case, we discern no sound reason for visiting the consequences of such error on the defendant by delaying the accrual of the claim until the plaintiff is otherwise informed or himself determines to bring suit, even though more than two years have passed from the plaintiff's discovery of the relevant facts about injury." Id.

In the present case, appellant was aware in April, 1963, that he had been injured and that the Sabin vaccine was the likely cause of his injury. ⁹ With knowledge of the fact of injury and its cause, appellant was at the time of his injury placed on the same footing as other negligence plaintiffs. The claim, then, accrued at the time of injury and the statute started to run. It was up to him to "determine within the period of limitations whether to sue or not." Id.

We conclude that in the absence of fraudulent concealment, appellant's claim against the United States was barred by limitations.

Fraudulent Concealment

Appellant contends that even if the cause of action accrued prior to 1973, the statute was tolled by the government's fraudulent concealment of the results of the second test during the October, 1965, deposition of Dr. Kirschstein. This argument fails, since the two-year period had already elapsed.

Appellant also argues that certain press releases and reports by the government indicating that there was no probable link between the taking of the vaccine and subsequent polio cases amounted to fraudulent concealment. This contention is meritless. ¹⁰ It may well be that the government was negligent in maintaining and publishing records. However, failure of the government to ascertain and publish the fact of its negligence is hardly sufficient to constitute fraudulent concealment. See Rutledge v. Boston Woven Hose & Rubber Co., 576 F.2d 248, 250 (9th Cir. 1978).

We conclude that appellant's action was barred by the applicable statute of limitations. The decision of the district court granting summary judgment is affirmed.

TANG, Circuit Judge, dissenting.

I respectfully dissent. Quite simply, the record fails to support the majority's assertion that "appellant was aware in April 1963, that the Sabin vaccine was the likely cause of Davis' injury." First, although Davis contacted polio in April 1963, he was hospitalized until October 25, 1963, and it is unclear when he had sufficiently recovered to be aware of anything. At best, the record indicates that Davis was functioning again in "approximately June, 1963" when he began to write letters inquiring about his disease. Clerk's Transcript Vol. IA, at 243.

More importantly, although Davis may have wondered in the summer of 1962 if the vaccine had induced his disease, "questioni...